A similar pattern of regulation was previously observed for instance for the oncogene BCL6 which is non-detectable at baseline but can strikingly be upregulated upon Imatinib (IM) treatment emitting its oncogenic function [13, 14] by allowing leukemia cells to escape TKI-mediated cell death. Here, BCL6 is linked to leukemia.